This drug manufacturing company has seen a mixed track record when it comes to estimate revisions of 1 increase and 1 decrease over the last 30 days. Meanwhile, the Zacks Consensus Estimate has remained unchanged over the same period. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
AstraZeneca currently bears a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Better-ranked Pharmaceutical stocks worth considering include AbbVie Inc. (ABBV), Allergan Inc. (AGN) and Johnson & Johnson (JNJ). All three stocks hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment